HomeCompareCTOWY vs MRK

CTOWY vs MRK: Dividend Comparison 2026

CTOWY yields 3.02% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CTOWY wins by $425.43M in total portfolio value
10 years
CTOWY
CTOWY
● Live price
3.02%
Share price
$15.50
Annual div
$0.47
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$425.48M
Annual income
$399,997,129.42
Full CTOWY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CTOWY vs MRK

📍 CTOWY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTOWYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTOWY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CTOWY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTOWY
Annual income on $10K today (after 15% tax)
$256.28/yr
After 10yr DRIP, annual income (after tax)
$339,997,560.01/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CTOWY beats the other by $339,989,231.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTOWY + MRK for your $10,000?

CTOWY: 50%MRK: 50%
100% MRK50/50100% CTOWY
Portfolio after 10yr
$212.77M
Annual income
$200,003,463.78/yr
Blended yield
94.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CTOWY
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
1.4
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTOWY buys
0
MRK buys
0
No recent congressional trades found for CTOWY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTOWYMRK
Forward yield3.02%2.76%
Annual dividend / share$0.47$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$425.48M$56.8K
Annual income after 10y$399,997,129.42$9,798.13
Total dividends collected$423.60M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: CTOWY vs MRK ($10,000, DRIP)

YearCTOWY PortfolioCTOWY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,303$603.01$11,206$366.19+$97.00CTOWY
2$13,368$1,273.98$12,650$502.35+$718.00CTOWY
3$17,120$2,816.35$14,407$694.19+$2.7KCTOWY
4$25,060$6,741.75$16,585$967.82+$8.5KCTOWY
5$45,260$18,445.76$19,342$1,363.89+$25.9KCTOWY
6$110,698$62,269.05$22,913$1,947.19+$87.8KCTOWY
7$403,114$284,667.67$27,662$2,823.89+$375.5KCTOWY
8$2,368,975$1,937,642.57$34,159$4,173.35+$2.33MCTOWY
9$23,818,749$21,283,946.25$43,337$6,308.80+$23.78MCTOWY
10$425,483,191$399,997,129.42$56,776$9,798.13+$425.43MCTOWY

CTOWY vs MRK: Complete Analysis 2026

CTOWYStock

China Tower Corporation Limited provides telecommunication tower infrastructure services in the People's Republic of China. The company engages in the construction, maintenance, and operation of base station ancillary facilities, such as telecommunications towers and public network coverage in high-speed railways and subways, and large-scale indoor distributed antenna systems. It offers towers, and shelters or cabinets; and ancillary equipment to telecommunication services providers for installation of the telecommunications equipment. The company also provides maintenance services, including monitoring equipment operation, routine inspection, device breakdown handling, property upkeep, working environment protection, and operation analysis services. In addition, it offers power access, batteries, or back up power generation to the customers' telecommunications equipment; and indoor distributed antenna systems connecting telecommunication equipment, enabling them to receive and send indoor mobile telecommunication network signals, as well as mobile telecommunication network signals covering buildings, large venues, and tunnels. Further, the company provides backup power services to standby emergency power supply to corporate customers; battery exchange services to replaceable batteries to individual customers; and battery recharge services to corporate and individual customers, as well as engages in the provision of integrated information, power generation, and energy storage services. Additionally, it provides trans-sector site application and information services. The company was formerly known as China Communications Facilities Services Corporation Limited and changed its name to China Tower Corporation Limited in September 2014. China Tower Corporation Limited was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.

Full CTOWY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CTOWY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTOWY vs SCHDCTOWY vs JEPICTOWY vs OCTOWY vs KOCTOWY vs MAINCTOWY vs JNJCTOWY vs ABBVCTOWY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.